1. Can quantitative 18F-FDG PET/CT and serum cytokine analysis differentiate ARVC from cardiac sarcoidosis?. (25th November 2020) Authors: Abbas, H; McKiddie, F; Kouri, M; Duncan, L; Fong, M; Wilson, E; Norris, K; Matheson, J; Scally, C; Dempsey, O; Denison, A; Wilson, H.M; Dawson, D.K; Broadhurst, P Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PTU-181 Optimised response prediction in oesophagogastric adenocarcinomas (OGA) with combination of molecular biomarkers, serum cell death markers and FDG-PET. (28th May 2012) Authors: Bain, G H; Collie-Duguid, E; Murray, G; Gilbert, F; Denison, A; McKiddie, F; Ahearn, T; Leeds, J; Phull, P; Park, K; Welch, A; Schweiger, L; Petty, R D Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗